Literature DB >> 2717130

Conversion of Lewis lung carcinoma into ascitic form.

T Sato1, K Takusagawa, N Asoo, N Kumano, M Hasuike, K Konno.   

Abstract

Lewis lung carcinoma (3LL), which has been most frequently used for various investigations of cancer, was converted to an ascitic form designated 3LL-SA. Ascites tumor cells showed a mixed population of single cells and about 10% islands which were made up of 2 to about 50 cells. Transplantability was 100%. The biological and metastatic capacities were preserved in this line as shown by its ability to form hemorrhagic and necrotic tumors, and by its multiple lung metastases. Moreover, histological and ultrastructural characteristics of this tumor line were identical to those of the parental 3LL. Thus, it can be seen that 3LL-SA will be a useful tool for the study of cancer.

Entities:  

Mesh:

Year:  1989        PMID: 2717130     DOI: 10.1159/000226712

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  2 in total

1.  Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis.

Authors:  Jun Zhao; Xiaoling Zhang; Yunyi Du; Lurong Zhou; Ziming Dong; Jimin Zhao; Jing Lu
Journal:  Hum Vaccin Immunother       Date:  2020-05-27       Impact factor: 3.452

2.  Role of macrophages in the host response to Lewis lung peritoneal carcinomatosis.

Authors:  M W Barth; P S Morahan
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.